14-day Premium Trial Subscription Sign Up For FreeGet Free

ADMA Biologics Inc Stock Forecast NASDAQ:ADMA

$1.42 (3.65%)

Volume: 3M

Closed: Jan 19, 2022

Hollow Logo Score: 2.320

ADMA Biologics Inc Stock Forecast

$1.42 (3.65%)

Volume: 3M

Closed: Jan 19, 2022

Score Hollow Logo 2.320

ADMA Biologics Inc Company Profile

465 Route 17 South

Ramsey NJ 07446



Industry: Biotechnology

Sector: Healthcare

ADMA Biologics Inc


ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate is RI-002, a plasma-derived, polyclonal immune globulin intravenous that is in Phase III clinical study for the treatment of primary immune deficiency disease. The company also operatesADMA BioCenters Georgia, Inc, which is a plasma collection center. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE